Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04760847 · ClinicalTrials.gov registry record · NA

Intermittent Fasting for Pancreatitis

A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Not yet
Registry status
NA
Development phase
64
Enrollment target

NCT04760847 is a NA study that has not yet begun recruiting, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 64 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04760847, a NA study, has not yet begun recruiting, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

NOT YET RECRUITING
Registry status
NA
Development phase
64 participants
Enrollment target

Study Summary

The purpose of this research is to compare intermittent fasting with a standard diet approach for improving the quality of life related to your pancreas disease. Our hope is to improve your symptoms and prevent you from needing to go into the hospital for pancreas-related issues.

Interventions

  • OTHER Intermittent Fasting
  • OTHER No intermittent fasting

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2026-03
Est. Completion 2026-04-01
Phase NA

What the Registry Record Tells You About NCT04760847

The ClinicalTrials.gov registry entry for NCT04760847 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Intermittent Fasting is the first listed.

NCT04760847 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04760847 about?

NCT04760847 is a clinical study titled "Intermittent Fasting for Pancreatitis". The purpose of this research is to compare intermittent fasting with a standard diet approach for improving the quality of life related to your pancreas disease. Our hope is to improve your symptoms and prevent you from needing to go into the hospital for pancreas-related issues.

What is the current status of trial NCT04760847?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2026-03. Estimated completion is 2026-04-01.

What interventions are being tested in trial NCT04760847?

The interventions under investigation include: Intermittent Fasting (OTHER), No intermittent fasting (OTHER).

Who is sponsoring clinical trial NCT04760847?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.